Mid-regional proadrenomedullin (MR-proADM), C-reactive protein (CRP) and other biomarkers in the early identification of disease progression in patients with COVID-19 in the acute NHS setting.
J Clin Pathol
; 76(6): 400-406, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-34996755
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
C-Reactive Protein
/
COVID-19
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
J Clin Pathol
Year:
2023
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom